Eyenuk received $25 million in Series A funding to expand access to its AI-powered eye-screening technology that enables autonomous detection of diabetic retinopathy (DR) during a patient's regular exam.
The recent raise was led by AXA IM Alts and joined by new and existing investors, including A&C Foelsgaard Alternativer ApS, T&W Medical A/S, KOFA Healthcare and Kendall Capital Partners...
Worldwide there are 422 million people living with diabetes, according to World Health Organization estimates. The condition can lead complications, including diabetic retinopathy, which can result in blindness. However, a recent study suggests artificial intelligence can help identify diabetic retinopathy early.
Researchers at the Medras Diabetes Research foundation in Chennai India found that a...
